Compare SCNI & NXAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCNI | NXAT |
|---|---|---|
| Founded | 2003 | 2023 |
| Country | Israel | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2M | 1.2M |
| IPO Year | 2014 | 2023 |
| Metric | SCNI | NXAT |
|---|---|---|
| Price | $1.55 | $0.22 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 103.0K | ★ 148.6K |
| Earning Date | 08-24-2026 | 12-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.21 | $0.30 |
| 52 Week High | $3.58 | $1.23 |
| Indicator | SCNI | NXAT |
|---|---|---|
| Relative Strength Index (RSI) | 77.95 | 23.41 |
| Support Level | $1.43 | N/A |
| Resistance Level | $1.76 | $0.53 |
| Average True Range (ATR) | 0.08 | 0.07 |
| MACD | 0.10 | 0.00 |
| Stochastic Oscillator | 93.78 | 2.18 |
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.
Nexus Advanced Technologies Inc pursuing strategic investments, acquisitions, and partnerships across AI infrastructure and technologies. The Company's ideas include opportunities involving data centers, AI compute and GPU infrastructure, and other technologies supporting the development and deployment of artificial intelligence. Nexus seeks to combine access to capital, strategic partnerships, and technology opportunities to build a diversified platform positioned to participate in the continued growth of world-wide AI infrastructure.